TAGRISSO 80 mg film-coated tablets, TAGRISSO 40 mg film-coated tablets
D5162C00048
Phase 2 small_molecule active
Quick answer
TAGRISSO 80 mg film-coated tablets, TAGRISSO 40 mg film-coated tablets for Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active